The Definitive Guide to tuberculosis treatment using saffron
Pretomanid is currently being analyzed as A part of a mixture regimen like moxifloxacin and PZA for the treatment of both equally drug-susceptible and drug-resistant tuberculosis (ClinicalTrials.gov identifier: NCT02193776). Bedaquiline, authorized through the US FDA for treatment of multidrug-resistant tuberculosis in 2012, can be remaining invest